| Meeting Brochure and registration form SMDM Homepage | |
|
|
|
||||
| Sunday, 23 October 2005: 7:00 AM-8:30 AM | |||
| Pacific Room EFG (Hyatt Regency San Francisco) | |||
| Poster Session II | |||
| 1 | IS ANTICOAGULATION JUSTIFIED IN PATIENTS WITH ATRIAL FLUTTER: A DECISION ANALYSIS MODEL Mitchell A. Medow, MD, PhD, MS, Mark A. Unroe, MD, MHA | ||
| 2 | *TRADE-OFFS BETWEEN HIP FRACTURE MORTALITY AND ORAL CORTICOSTEROID USAGES AMONG WHITE MEN AND WOMEN SeungJin Bae, A. David Paltiel, PhD, Anne L. Fuhlbrigge, MD, MS, Karen M. Kuntz, ScD | ||
| 3 | EVALUATING AN INDIVIDUALIZED INFORMATION DECISION SUPPORT INTERVENTION IN URO-ONCOLOGY B. Joyce Davison, PhD, MN, BN | ||
| 4 | DECISION ANALYSIS OF THE EFFECTIVENESS OF CONTRACEPTION BY IMMEDIATE VERSUS DELAYED INSERTION OF INTRA-UTERINE DEVICES AFTER ABORTION Matthew F. Reeves, MD, Kenneth J. Smith, MD, Mitchell D. Creinin | ||
| 5 | *A COST-EFFECTIVENESS ANALYSIS BASED ON THE ASCUS AND LSIL TRIAGE STUDY (ALTS) Jane J. Kim, MS, Shalini Kulasingam, PhD, William F. Lawrence, MD, MSc, Jeanne Mandelblatt, MD, MPH, Evan Myers, MD, MPH, Mark Schiffman, MD, MPH, Diane Solomon, MD, Sue J. Goldie, MD, MPH | ||
| 6 | EXTENDING THE ACCESSIBILITY OF MARKOV MODELS IN HEALTH TECHNOLOGY ASSESSMENT USING VISUALISATION TOOLS Martin A. Pitt, EngD. | ||
| 7 | *COST EFFECTIVENESS ANALYSIS OF MORBID OBESITY SURGICAL STRATEGIES Benjamin K. Poulose, MD, MPH, Theodore Speroff, PhD, Michael D. Holzman, MD, MPH, Marie R. Griffin, MD, MPH | ||
| 8 | *PHARMACOGENOMICS AS A MECHANISM TO IMPROVE CARDIOVASCULAR OUTCOMES: SCREENING FOR THE ALPHA-ADDUCIN VARIANT Lisa M. Meckley, BA, David L. Veenstra, PharmD, PhD | ||
| 9 | ANASTRAZOLE FOR BREAST CANCER CHEMOPREVENTION: AN ECONOMIC ANALYSIS Samuel Cykert, MD, Nancy Phifer, MD | ||
| 10 | *PHARMACOECONOMIC ANALYSIS: EXPLORATORY ESTIMATION OF THE COST-EFFECTIVENESS OF RITUXIMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN CANADA Ivan Kasule | ||
| 11 | EVALUATING THE COST-EFFECTIVENESS OF DRUG-ELUTING CORONARY STENTS: THE RESULTS OF A BAYESIAN EVIDENCE SYNTHESIS AND DECISION MODEL Neil Hawkins, PhD, Mark Sculpher, PhD | ||
| 12 | *COST EFFECTIVENESS ANALYSIS OF TESTING STRATEGIES FOR THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Natalya Danchenko, PhD, Susan Manzi, MD, MPH, Thomas J. Songer, PhD | ||
| 13 | OSELTAMIVIR (TAMIFLU) FOR PANDEMIC INFLUENZA - COST-EFFECTIVE BUT TOO EXPENSIVE? Torbjørn Wisløff, M.Sc., Lars R. Håaheim, Jan Eilert Fuglesang, Haakon Sjursen, Ragnar Salmén, Arne B. Brantsæter, Øistein Løvoll, Ellen M. Nilsen, PhD, Ivar S.ønbø Kristiansen, PhD | ||
| 14 | A METHOD FOR IDENTIFYING OPTIMUM TREATMENT SEQUENCES IN CHRONIC DISEASES Neil Hawkins, MSc, PhD, Mark Sculpher, PhD, Karl Claxton, PhD, MSc, BA | ||
| 15 | ROBUST APPROACH TO STOCHASTIC COST-EFFECTIVENESS ANALYSIS USING NET BENEFITS FROM AN INDIVIDUAL PATIENT DATA META-ANALYSIS Aletta B. S. Nonyane, PhD, Michelle Qume, PhD, Brendan C. Delaney, MD | ||
| 16 | A COMPARISON OF NET BENEFIT ANALYSIS METHODS Paul Kolm, PhD, Emir Veledar, PhD, Joseph Jackson, PhD, Sylvie Gabriel, Olivier Bouin, MD, William S. Weintraub, MD | ||
| 17 | MODELLING COST-EFFECTIVENESS OF PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS; ‘HARD' PROXY RCT VS CLINICAL OUTCOME META-ANALYSES Ron NJ De Nijs, E. Buskens, Chris ED De Laet, Hans WG Jacobs, Hans WJ Bijlsma on behalf of the STOP study group | ||
| 17 | *THE EFFECTIVENESS AND COSTS OF REDUCING LOSS TO FOLLOW-UP IN A SOUTH AFRICAN CERVICAL CANCER SCREENING STUDY Jeremy D. Goldhaber-Fiebert, AB, Lynette Denny, MD, PhD, Michelle De Souza, MD, Thomas C. Wright, MD, Sue J. Goldie, MD, MPH | ||
| 18 | *EFFECTS OF CATEGORIZING CONTINUOUS RISK FACTORS IN DECISION-ANALYTIC MODELING Tanya G.K. Bentley, Ph.D., Karen M. Kuntz, ScD | ||
| 20 | *AN EXPLORATORY COST-EFFECTIVENESS MODEL OF HPV VACCINATION IN TANZANIA Jeremy D. Goldhaber-Fiebert, AB, Sonia R. Pagliusi, MD, Steven Sweet, BS, Sue J. Goldie, MD, MPH | ||
| 21 | PRESENTING COST-EFFECTIVENESS INFORMATION FOR A HETEROGENEOUS POPULATION: AN ILLUSTRATION BASED ON A MODEL OF ACE-INHIBITION IN CARDIOVASCULAR DISEASE Andrew Briggs, DPhil, Borislava Mihaylova, MSc, Mark Sculpher, PhD, Alistair Hall, MD, Jaap Deckers, MD, Maarten Simoons, MD, Kim Fox, MD | ||
| 22 | LOCATION SPECIFIC COST EFFECTIVENESS OF PUBLIC ACCESS DEFIBRILLATION Douglas Coyle, PhD, Kathryn O'Grady, MSc, Valerie J. De Maio, MD, Ian Stiell, MD | ||
| 23 | MODELING TOTAL ANNUAL COST OF MONTELUKAST IN THE TREATMENT OF ASTHMA WITH CONCOMITANT ALLERGIC RHINITIS IN FRANCE Sabine Gaugris, MSc., Vasilisa Sazonov Kocevar, PhD | ||
| 24 | WHAT'S FAIR? THE ATTRIBUTES OF EQUITABLE HEALTH CARE RESOURCE ALLOCATION DECISIONS Ahmed M. Bayoumi, MD, MSc, Jeffrey Hoch, PhD | ||
| 25 | THE EFFECT OF ANTIRETROVIRAL THERAPY ADHERENCE PROGRAMS FOR HIV-INFECTED INDIVIDUALS ON HEALTH CARE UTILIZATION Stephanie Sansom, PhD, MPP, MPH, Monique Anthony, Wendy Garland, MPH, Paul Weidle, PharmD, MPH, Mary Jo Earp, Rosa Valencia, MPH, Amy Wohl, PhD, MPH, Mallory Witt, MD | ||
| 26 | PATIENT-PHYSICIAN COLORECTAL CANCER SCREENING DISCUSSIONS Jennifer Elston Lafata, PhD, Christina Moon, MA, George Divine, PhD, L.Keoki Williams, MD, MPH | ||
| 27 | COMBINATION VERUS MONOTHERAPIES FOR PREVENTING STROKE RECURRENCE Antoine C. El Khoury, PhD, Fadia T. Shaya, PhD, MPH, C.Daniel Mullins, PhD, Matthew R. Weir, MD, Hugh Fatodu, RPh, Howard Garber, MD, MPH | ||
| 28 | FEAR OF BREAST CANCER RECURRENCE, INTERPRETATION OF NEW SYMPTOMS AND HEALTH CARE UTILIZATION Andrea D. Gurmankin, PhD, MBe, Ellyn Micco, BA, Eric Winer, M.D., Lorraine D. Dean, BA, Susan Domchek, M.D., Katrina Armstrong, M.D., M.S. | ||
| 29 | *VARIABLES ASSOCIATED WITH PHYSICIANS' ANXIETY AND RELUCTANCE TO SHARE UNCERTAINTY WITH PATIENTS IN THE CONTEXT OF SHARED DECISION MAKING France Legare, MD, PhD, FCFP, Lucile Turcot, MD, PhD, Hubert Marcoux, MD, MSc, Ian Graham, PhD, Annette M. O'Connor, PhD | ||
| 30 | *THE EFFECT OF OUTCOME INFORMATION ON DOCTORS' SPONTANEOUS LEARNING Ketti Mazzocco, PhD-student, Rino Rumiati, prof., Paolo Cherubini, PhD | ||
| 31 | TRANSLATING RESEARCH INTO PRACTICE? UNFORESEEN HURDLES IN THE IMPLEMENTATION OF A DECISION AID RESEARCH PROJECT IN A HEALTHCARE SETTING Sarah M. Greene, MPH, Peter A. Ubel, MD, Jennifer B. McClure, PhD, Karen E. Johnson, PhD, Brian J. Zikmund-Fisher, PhD, Holly A. Derry, MPH, Azadeh Stark, PhD, Sarah L. Claud, MPH, Angela Fagerlin, PhD | ||
| 32 | *THE VALUATION OF MULTI-ATTRIBUTE HEALTH STATES AND RESPONDENTS' HEURISTICS Marieke Verschuuren, MD, Ben A. Van Hout, PhD, Gouke J. Bonsel, MD, PhD | ||
| 33 | VALUATION MODELING FOR ASSESSING BIOTECHNOLOGY AND PHARMACEUTICAL DEVELOPMENTAL OPPORTUNITIES Lesley G. Shane, PharmD, Fred Cox, PhD, John Vernon, PhD | ||
| 34 | THE JUDGEMENT AND DECISION MAKING PERFORMANCE IN PRACTICE (JDM-PIP) TOOL: AN IDIOGRAPHIC ASSESSMENT TOOL TO SUPPORT CRITICAL REFLECTION ON PRACTICE Padraig Mac Neela, PhD, P. Anne Scott, PhD, Margaret P. Treacy, PhD, Abbey Hyde | ||
| 35 | DEVELOPMENT, SCORING AND VALIDATION OF A PATIENT-MANAGEMENT TOOL IN SPECIFIC IMMUNO-THERAPY Benoit Arnould, MSc, MA, Khadra Benmedjahed, Riad Fadel, MD, Catherine Bos, Jean-François Fontaine, MD, Thierry Haddad, MD, Pascale Mathelier Fusade, MD, Patrick Rufin, MD, François Saint-Martin, MD, Jacques Zekri, MD | ||
| 36 | A DECISION AID CROSSES THE DIGITAL DIVIDE: INSIGHTS AND IMPLICATIONS FOR DECISION AID RESEARCH Deb Feldman-Stewart, PhD, Michael Brundage, MD, Sarah Brennenstuhl, BA, Vladimir Zotov, MA, Tom Roques, MD, Rob Siemens, MD, Hollly Campbell, MD, Tom Pickles, MD | ||
| 37 | *A MARKOV MODEL OF THE NATURAL HISTORY OF HIV Steven M. Shechter, MS, Andrew J. Schaefer, PhD, Joyce C. Chang, PhD, R. Scott Braithwaite, MD, MSc, Mark S. Roberts, MD, MPP | ||
| 38 | BENEFIT HARM TRADE-OFFS ESTIMATE SUFFICIENTLY IMPORTANT DIFFERENCE FOR COMMON COLD TREATMENTS Bruce P. Barrett, MD, PhD, David D. Brown, PhD | ||
| 39 | VALUE OF USABILITY TESTING OF DECISION SUPPORT TOOLS PRIOR TO CLINICAL USE: EXAMPLE USING ANTICOAGULATION IN ATRIAL FIBRILLATION Mark Wess, MD, Jason Saleem, PhD, MS, Sara E. Luckhaupt, M.D., Joseph A. Johnston, MD, MSc, Ruth Shaull, MSN, RN, Jonathan Kopke, Joel Tsevat, MD, MPH, Mark Eckman, MD, MS | ||
| 40 | *THREE-CLASS ROC ANALYSIS — DECISION THEORETIC APPROACHES Xin He, BS, Jonathan M. Links, PhD, Benjamin M. W. Tsui, PhD, Eric C. Frey, PhD | ||
| 41 | *DETERMINATION OF NON-CONSTANT INTRACRANIAL ANEURYSM GROWTH BY SIMULATION H. Koffijberg, M.J.H. Wermer, E. Buskens on behalf of the ASTRA study group | ||
| 42 | NATURALISTIC DECISION PROCESSES AMONG WOMEN FACING RECURRENT BREAST CANCER Penny F. Pierce, PhD, RN | ||
| 43 | USE OF A NUMERICAL FORMAT ASSISTS PATIENTS IN CONSISTENTLY WEIGHING RISKS OF CHILDBIRTH IN A RANDOMIZED TRIAL Karen B. Eden, PhD, James G. Dolan, MD, Nicholas Anderson, MS, Deborah Rosenberg, BA, Jennifer Jimison, MPA, Megan McClelland, MS, Nancy Perrin, PhD, Jeanne Marie Guise, MD, MPH | ||
| 44 | *DECIDING THE CONTENT OF WRITTEN PATIENT INFORMATION MATERIALS IS NOT A SIMPLE MATTER OF FOLLOWING GUIDELINES Heather M. Davey, MPH(Hons), Alexandra Barratt, MD, PhD, Phyllis N. Butow, MClinPsych, PhD, Nehmat Houssami, MBBS, PhD | ||
| 45 | THE INFLUENCE OF BELIEF IN LUCK ON CHOICES INVOLVING UNCERTAINTY Carol K. Stockman, PhD, Mark S. Roberts, MD, MPP | ||
| 46 | *WILLINGNESS-TO PAY FOR ANTIEMETIC REGIMENS FOR PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING Reema Mody, MBA, BS, Lesley-Ann N. Miller, PhD, MS | ||
| 47 | "SNAP-ON" TOOLS FOR STATIN DECISION MAKING: PATIENTS' DECISION HEURISTICS Michael A. Crouch, MD, MSPH, Simon Whitney, MD, JD, Robert Volk, Viola Benavidez | ||
| 48 | TELEPHONE SURVEY OF CHILD PSYCHIATRISTS ABOUT THE DIAGNOSIS OF BIPOLAR DISORDER Cathryn A. Galanter, MD, Carrie Wong, BA, Dana Pagar, BA, Maura Sabatos, BS, Peter S. Jensen, MD | ||
| 49 | A SITUATION SPECIFIC MODEL OF REPRODUCTIVE DECISION MAKING Elisabeth Howard, CNM, MSN | ||
| 50 | DOES RACE MATTER IN THE DECISION TO OFFER GENETIC SCREENING? Vence L. Bonham, JD, Adebola Odunlami, MPH, Esther Warshauer Baker, BS, Jean Jenkins, PhD, Nancy Stevens, MD, MPH, Zintesia Page, MS, Colleen McBride, PhD | ||
| 51 | *ENERGY IMBALANCE AMONG U.S. CHILDREN: A COUNTERFACTUAL APPROACH Y. Claire Wang, MD, MS, Steven L. Gortmaker, PhD, Sara N. Bleich, BA, Karen M. Kuntz, ScD | ||
| 52 | DIFFERENCES IN CANCER RISK PERCEPTION AMONG DIVERSE WOMEN Sue E. Kim, PhD, MPH, Sabrina T. Wong, PhD, RN, Eliseo Pérez-Stable, MD, Celia Kaplan, DrPH, Judith Walsh, MD, MPH, George Sawaya, MD | ||
| 53 | SELLING PURPLE PILLS: INFORMATION AND PERSUASIVE THEMES IN TELEVISION ADVERTISING OF PRESCRIPTION PHARMACEUTICALS Dominick L. Frosch, PhD, Patrick Krueger, PhD, Frances Barg, PhD | ||
| 54 | *LEVERAGING DATA FROM TWO HIGH-RISK COUNTRIES TO DEVELOP A NATURAL HISTORY MODEL OF GASTRIC CANCER Jennifer M. Yeh, MS, Karen M. Kuntz, ScD, Majid Ezzati, PhD, Sue J. Goldie, MD, MPH | ||
| 55 | *A COMBINED QUEUING/SIMULATION MODEL OF MASS PROPHYLAXIS Daniel Wattson, BS, Nathaniel Hupert, MD, MPH | ||
| 56 | A PUBLIC ACCESS DEFIBRILLATION SCHEME IN NORTHERN IRELAND: EXPLORING THE IMPACT OF A MOBILE VOLUNTEER'S AVAILABILITY Karen J. Cairns, PhD, Adele H. Marshall, PhD, Frank Kee, MD, Michael J. Moore, MD, A. A. Jennifer Adgey, MD | ||
| 57 | *PARAMETERIZATION OF A NATURAL HISTORY MODEL OF CERVICAL CANCER USING LATIN HYPERCUBE SAMPLING AND GOODNESS OF FIT ALGORITHMS Nicolas Van de Velde, MSc, Marc Brisson, PhD, Marie-Claude Boily, PhD | ||
| 58 | *PREDICTING DISEASE PROGRESSION USING DYNAMIC SIMULATION IN PNEUMONIA-RELATED SEPSIS Gorkem Saka, MS, Jennifer Kreke, MS, Andrew J. Schaefer, Derek C. Angus, Mark S. Roberts | ||
| 59 | COST-EFFECTIVENESS OF ENDOVASCULAR VERSUS CONVENTIONAL ABDOMINAL AORTIC ANEURYSM REPAIR; LONG TERM INTEREST YET ONE YEAR DATA SUFFICE. RESULTS OF A RANDOMIZED TRIAL Erik Buskens, Monique Prinssen, Sjors ECA De Jong, Jan D. Blankensteijn on behalf of the DREAM study group | ||
| 60 | THE OPTIMAL PEAK SYSTOLIC VELOCITY THRESHOLD ON DUPLEX ULTRASONOGRAPHY FOR THE INDICATION CAROTID ENDARTERECTOMY: A DECISION ANALYTIC APPROACH Majanka H. Heijenbrok-Kal, PhD, Erik Buskens, MD, PhD, Paul J. Nederkoorn, MD, PhD, Yolanda Van der Graaf, MD, PhD, M.G. Myriam Hunink, MD, PhD | ||
See more of The 27th Annual Meeting of the Society for Medical Decision Making (October 21-24, 2005)
Papers submitted for the Lee B. Lusted Student Prize Competition are denoted with an asterisk (*)